Ortin Laboratories Ltd banner
O

Ortin Laboratories Ltd
NSE:ORTINLAB

Watchlist Manager
Ortin Laboratories Ltd
NSE:ORTINLAB
Watchlist
Price: 19.63 INR Market Closed
Market Cap: ₹159.6m

Ortin Laboratories Ltd
Investor Relations

Ortin Laboratories Ltd. engages in the manufacture of drug intermediates and pharmaceuticals products. The company is headquartered in Hyderabad, Telangana. The company manufactures a range of pharmaceutical formulations of tablets, capsules, syrups and dry powders. The firm's products include Acefinac, ACEFINAC-CZ, ACEFINAC-P, ACEFINAC-SP, ACTAZID, ACTY-P, ALERFEX-120, ALERFEX-180, ALERGID, ALERGID- L, AMLOBID, CARBAMOL, CARISNIL, CALDY-C AZITIN-500, DOCEF-200, GLYCITROL, GLYCITROL-M, LORACT, MEBOL, NEUROCOB, FERUP, IRFER Z, MINVITA-B, NILCID, ORICILLIN-DX, PEG POWDER, PEG-D POWDER, ALKASIT, COF-XL, DECODIL, ENCENIL and OROMOX DRY SYRUP. Its formulations include Anti Diabetics, Anti Allergics, Anti Anginal and Cardiovascular, Analgesics and Antipyretics, and Anti Biotics-Quinolones. Its active pharmaceutical ingredient (API) intermediates include Anti retro viral, Grignard, Diborane, Ciprofloxacin and Tramadol. The company is also manufacturing for different importers to market their products in Russia, Ukraine, Kajakistan and South America.

Show more
Loading
ORTINLAB
BSE Sensex 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Sanka Murali Krishna Murthy
CEO & MD
No Bio Available
Mr. Sanka Srinivasa Kumar
CFO & Whole Time Director
No Bio Available

Contacts

Address
TELANGANA
Hyderabad
1-2-593/29, Ground Floor, Street No.4, Gagan Mahal Colony,
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett